COOPER COMPANIES, INC. 10-K

Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Our common stock, par value $0.10 per share, is traded on the Nasdaq under the symbol “COO.” As of December 1, 2025, there were 141 common stockholders of record. Dividends In December 2023, our Board of Directors decided to end the declaration of the semiannual dividend. Any future determination to pay dividends will be made at the discretion of our Board of Directors subject to applicable laws and will depend on, among other factors, our results of operations, financial condition, contractual restrictions and capital requirements. Performance Graph This performance graph shall not be deemed “soliciting material” or to be “filed” with the SEC for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act, except as shall be expressly set forth by specific reference in such filing. The following graph compares the cumulative total return on our common stock with the cumulative total return of the Standard & Poor 500 and the Standard & Poor's Health Care Equipment Index for the five-year period ended October 31, 2025. The graph assumes that the value of the investment in Cooper and in each index was $100 on October 31, 2020, and assumes that all dividends were reinvested. COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN* Among The Cooper Companies, Inc., the S&P 500 Index and the S&P Health Care Equipment Index *$100 invested on October 31, 2020, in stock or index, including reinvestment of dividends. Fiscal year ending October 31. Copyright© 2025 Standard & Poor's, a division of S&P Global. All rights reserved. 44 THE COOPER COMPANIES, INC. AND SUBSIDIARIES Issuer Purchases of Equity Securities In September 2025, the authorization under the 2012 Share Repurchase Program was increased to $2.0 billion by the Company's Board of Directors. As of October 31, 2025, $966.4 million remains authorized for repurchase. The following table provides information about the shares repurchased by the Company for the three months ended October 31, 2025: Period Total number of shares purchased (in thousands) Average price paid per share Total number of shares purchased as part of publicly announced plan (in thousands) Approximate dollar value of shares that may yet be purchased under the plan (in millions) August 1, 2025 to August 31, 2025 399.4 $ 65.68 399.4 $ 137.4 September 1, 2025 to September 30, 2025 2,006.2 $ 67.08 2,006.2 $ 1,002.8 October 1, 2025 to October 31, 2025 517.9 $ 70.40 517.9 $ 966.4 Total 2,923.5 $ 67.48 2,923.5 Unregistered Sales of Equity Securities None. Equity Compensation Plan Information The following table sets forth certain information as of October 31, 2025, concerning the shares of our Common Stock that may be issued under any form of award granted under our equity compensation plans in effect as of October 31, 2025: Plan Category Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (1) (A) Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights (2) (B) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column A) (3) (C) Equity compensation plans approved by shareholders 5,444,288 $77.54 7,882,366 Equity compensation plans not approved by shareholders — — — Total 5,444,288 $77.54 7,882,366 (1) Includes (i) 1,211,579 shares subject to outstanding Restricted Stock Units (RSU), (ii) 744,980 shares subject to outstanding Performance Share Units (PSU), calculated at the maximum potential payout and (iii) 3,487,729 shares subject to outstanding options. Does not include rights to purchase shares under the 2019 Employee Stock Purchase Plan (the "2019 ESPP" or the "ESPP"), which depend on a number of factors described in the 2019 ESPP. (2) The weighted-average exercise price is calculated based solely on the exercise prices of outstanding options and do not reflect shares to be issued upon the vesting of RSUs and PSUs, which have no exercise price. (3) Includes (i) 4,315,716 shares available for issuance under the 2023 Plan, (ii) 3,499,807 s hares available for issuance under the 2019 ESPP and (iii) 66,843 shares available for issuance under the 2020 Long Term Incentive Plan for Non-Employee Directors. Item 6. Reserved 45 THE COOPER COMPANIES, INC. AND SUBSIDIARIES Management’s Discussion and Analysis of Financial Condition and Results of Operations